Frontiers in Drug Discovery | Technologies and Strategies to Enable Drug Discovery

Mini Review

Published on 30 Nov 2023

Introduction to small molecule drug discovery and preclinical development

in Technologies and Strategies to Enable Drug Discovery

Michelle W. Y. Southey
Michael Brunavs

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1314077

28,805 views
10 citations

Original Research

Published on 30 Oct 2023

An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia

in Technologies and Strategies to Enable Drug Discovery

Manisha Padmakumar
Steven Biesmans
Jorge S. Valadas
Jan R. Detrez
Gaëlle Gillet
Priscillia Bresler
Marie-Laure Clénet
Irena Kadiu

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1289314

1,894 views

Mini Review

Published on 05 Sep 2023

Harnessing bioluminescence for drug discovery and epigenetic research

in Technologies and Strategies to Enable Drug Discovery

Hannah J. Gleneadie
Andrew Dimond
Amanda G. Fisher

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1249507

2,491 views
1 citation

Mini Review

Published on 12 Jul 2023

FAIR data management: what does it mean for drug discovery?

in Technologies and Strategies to Enable Drug Discovery

Yojana Gadiya
Vassilios Ioannidis
David Henderson
Philip Gribbon
Philippe Rocca-Serra
Venkata Satagopam
Susanna-Assunta Sansone
Wei Gu

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1226727

2,160 views
3 citations

Mini Review

Published on 24 May 2023

Drug discovery and development: introduction to the general public and patient groups

in Technologies and Strategies to Enable Drug Discovery

Natesh Singh
Philippe Vayer
Shivalika Tanwar
Jean-Luc Poyet
Katya Tsaioun
Bruno O. Villoutreix

Frontiers in Drug Discovery

doi 10.3389/fddsv.2023.1201419

112,393 views
40 citations

Original Research

Published on 12 Jan 2023

The use of cyclic peptide antigens to generate LRP8 specific antibodies

in Technologies and Strategies to Enable Drug Discovery

Maria A. Argiriadi
Kangwen Deng
David Egan
Lei Gao
Farid Gizatullin
John Harlan
Denise Karaoglu Hanzatian
Wei Qiu
Ruth Villanueva
Andrew Goodearl

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.1093153

2,544 views
2 citations

Opinion

Published on 24 Aug 2022

Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD

in Technologies and Strategies to Enable Drug Discovery

Yuhai Zhao
Vivian R. Jaber
Walter J. Lukiw

Frontiers in Drug Discovery

doi 10.3389/fddsv.2022.983030

1,377 views
6 citations

Navigation group

Articles

Introduction to small molecule drug discovery and preclinical development

An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia

Harnessing bioluminescence for drug discovery and epigenetic research

FAIR data management: what does it mean for drug discovery?

Drug discovery and development: introduction to the general public and patient groups

The use of cyclic peptide antigens to generate LRP8 specific antibodies

Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD